International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson’s Disease at the Neuroscience 2016 Conference
November 10, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 10, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation Announces Positive Efficacy Results in Traumatic Brain Injury
October 18, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation Publishes Results of Safety Studies Conducted in Support of the First Human Pluripotent Stem Cell Based Therapy for Parkinson’s Disease
October 05, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 05, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation to Present at the 18th Annual Rodman and Renshaw Global Investment Conference
September 07, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...
International Stem Cell Corporation Announces Operating Results for the Three and Six-Months Ended June 30, 2016
August 16, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Aug. 16, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based biotechnology...
International Stem Cell Corporation Announces Successful Cell Transplantation for the First Patient in Phase 1 Clinical Trial of ISC-hpNSC
July 28, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., July 28, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...
International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation
June 02, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - June 02, 2016) - International Stem Cell Corporation (OTCQB: ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation Announces Operating Results for the Three-Months Ended March 31, 2016
May 17, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - May 17, 2016) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Announces 2015 Fourth Quarter and Year-End Results
March 31, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - March 31, 2016) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation to Raise $6.3 Million Through a Private Placement to Fund Phase I Clinical Trial
March 10, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, CA--(Marketwired - March 10, 2016) - International Stem Cell Corporation (OTCQB: ISCO), a clinical stage biotechnology company developing novel stem cell-based therapies and biomedical...